Ph. Bhagavan P S RPh's blog
I came across while browsing, another interesting write up in the American Journal of Pharmaceutical Education 2013; 77 (7) Article 157. which I would like to share with my pharma friends;
A typical situation through which I came through where I was advised not to introduce any system where functionaries will have to go in for learning certain unfamiliar SOPs and updating.
we slide forward
with the memory
I dont call this a blog but a piece of information that I had shared with the reporter of the pharma news tabloid called 'Pharmabiz' and the same had appeared on Oct 5 2013 issue.
I am sharing the same for the benefit of the pharmainfo.net browsers:
I am writing this blog in response to the brutal attack on an innocent woman in a Bangalore ATM snatching perhaps the best moments of her life on her daughter's birth day.I pray for her speedy recovery.
Drugs and formulations are banned by the Govt when they are found to be harmful when used in the indicated dose. Without dwelling into the banning process, I wish to focus on the issues that arise at many levels including the patient per se, consequent to banning. This is also a part of pharmacy practice.
Dr Vijayaratna has rightly pointed out in her comment to my 80th blog that :